Company Search:
Advanced Search
Sponsored Links
Stemline Therapeutics Inc Company Snapshot
Stemline Therapeutics Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Stemline Therapeutics Inc with three other companies in this sector in the United States: Corbus Pharmaceuticals Holdings Inc (2015 sales of $648,382.00 of which 100% was Therapeutics), Marina Biotech Incorporation ($680,000.00 ), and Genocea Biosciences Inc ($670,000.00 of which 100% was Discovers and Develops Novel Vaccines).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Stemline Therapeutics Inc
  Stock Performance Chart for Stemline Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 12.95
(Figures in U.S. Dollars)
1 Week 0.4%   13 Weeks 14.6%  
4 Weeks -4.8%   52 Weeks 166.5%  
Stemline Therapeutics Inc Key Data:
  Ticker: STML Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 654,160
(Year Ending Jan 2016).
Employees: 24
  Currency: U.S. Dollars Market Cap: 248,105,579
  Fiscal Yr Ends: December Shares Outstanding: 19,158,732
  Share Type: Common Closely Held Shares: 2,379,110
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.